- Study of Yescarta patients reveals genetic red flags for CAR-T therapy side effectsA new analysis of patients who took part in clinical trials for Kite Pharma’s CAR-T cell therapy Yescarta has revealed genetic signatures of toxicity risk, potentially providing a path forward for…Fierce Biotech · 2d ago↗ source
- A new, separate outbreak of the diarrhea-causing parasiteA win for peptide proponents, autism advisory committees clash, and more health news from Morning RoundsSTAT · 2d ago↗ source
- Michael Ehlers joins Formation Bio to lead R&D; Black Diamond co-founder dies at 67Michael Ehlers left his CEO role at Ascidian Therapeutics, the exon editing company he co-founded, to run R&D at the AI biotech Formation Bio. It’s not often that biotech executives leave ...